145 related articles for article (PubMed ID: 37085532)
1. A big data-based prediction model for prostate cancer incidence in Japanese men.
Kato M; Horiguchi G; Ueda T; Fujihara A; Hongo F; Okihara K; Marunaka Y; Teramukai S; Ukimura O
Sci Rep; 2023 Apr; 13(1):6579. PubMed ID: 37085532
[TBL] [Abstract][Full Text] [Related]
2. Ethnic differences in the age-related distribution of serum prostate-specific antigen values: A study in a Taiwanese male population.
Tsai TH; Chu TW; Lin TH; Hsieh TF; Chen CC; Liu HH; Chuang YC; Lin CW; Lee SS
PLoS One; 2023; 18(3):e0283040. PubMed ID: 36928100
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
4. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy.
Ochiai A; Okihara K; Kamoi K; Oikawa T; Shimazui T; Murayama S; Tomita K; Umekawa T; Uemura H; Miki T
BJU Int; 2013 May; 111(6):928-33. PubMed ID: 23331404
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of prostate specific antigen for early stage prostate cancer detection.
Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J; Saitoh M; Watanabe H; Ohe H
Jpn J Clin Oncol; 1994 Jun; 24(3):160-5. PubMed ID: 7516445
[TBL] [Abstract][Full Text] [Related]
7. Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening.
Oki R; Ito K; Suzuki R; Fujizuka Y; Arai S; Miyazawa Y; Sekine Y; Koike H; Matsui H; Shibata Y; Suzuki K
Int J Cancer; 2018 Oct; 143(7):1611-1619. PubMed ID: 29696637
[TBL] [Abstract][Full Text] [Related]
8. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.
Oesterling JE; Kumamoto Y; Tsukamoto T; Girman CJ; Guess HA; Masumori N; Jacobsen SJ; Lieber MM
Br J Urol; 1995 Mar; 75(3):347-53. PubMed ID: 7537604
[TBL] [Abstract][Full Text] [Related]
9. Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population.
Kobayashi T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
Urology; 2004 Apr; 63(4):727-31. PubMed ID: 15072889
[TBL] [Abstract][Full Text] [Related]
10. Distributions and characteristics of initial PSA and PSA velocity in Chinese men aged 50 years and younger without prostate cancer: a multi-center study.
Yang W; Liu S; Hu C; Xie K; Wei X; Zeng W; Tang P
J BUON; 2019; 24(2):832-837. PubMed ID: 31128043
[TBL] [Abstract][Full Text] [Related]
11. The outcome of prostate cancer screening in a normal Japanese population with PSA of 2-4 ng/ml and the free/total PSA under 12%.
Ishidoya S; Ito A; Orikasa K; Kawamura S; Tochigi T; Kuwahara M; Yamanobe T; Tomita Y; Masumori N; Tsukamoto T; Shibuya D; Arai Y
Jpn J Clin Oncol; 2008 Dec; 38(12):844-8. PubMed ID: 18941125
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer.
Ito K; Yamamoto T; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2000 Aug; 56(2):278-82. PubMed ID: 10925094
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.
Berger AP; Deibl M; Steiner H; Bektic J; Pelzer A; Spranger R; Klocker H; Bartsch G; Horninger W
Prostate; 2005 Aug; 64(3):240-5. PubMed ID: 15712213
[TBL] [Abstract][Full Text] [Related]
14. The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required?
Gerstenbluth RE; Seftel AD; Hampel N; Oefelein MG; Resnick MI
J Urol; 2002 Nov; 168(5):1990-3. PubMed ID: 12394692
[TBL] [Abstract][Full Text] [Related]
15. Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml.
Shao YH; Albertsen PC; Roberts CB; Lin Y; Mehta AR; Stein MN; DiPaola RS; Lu-Yao GL
Arch Intern Med; 2010 Jul; 170(14):1256-61. PubMed ID: 20660846
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen levels in men aged 70 years and over: findings from the CHAMP study.
Litchfield MJ; Cumming RG; Smith DP; Naganathan V; Le Couteur DG; Waite LM; Blyth FM; Handelsman DJ
Med J Aust; 2012 Apr; 196(6):395-8. PubMed ID: 22471541
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer risk assessment in men with an initial P.S.A. below 3 ng/mL: results from the Göteborg randomized population-based prostate cancer screening trial.
Frånlund M; Arnsrud Godtman R; Carlsson SV; Lilja H; Månsson M; Stranne J; Hugosson J
Scand J Urol; 2018 Aug; 52(4):256-262. PubMed ID: 30241447
[TBL] [Abstract][Full Text] [Related]
18. [Advantages and risks of the use of prostate-specific antigen (PSA) in the health-care area No. 4 of Gijon (Asturias)].
Cepeda Piorno J; Rivas del Fresno M; Fuente Martín E; González García E; Muruamendiaraz Fernández V; Fernández Rodríguez E
Arch Esp Urol; 2005 Jun; 58(5):403-11. PubMed ID: 16078781
[TBL] [Abstract][Full Text] [Related]
19. Age-specific PSA reference ranges in Chinese men without prostate cancer.
Liu ZY; Sun YH; Xu CL; Gao X; Zhang LM; Ren SC
Asian J Androl; 2009 Jan; 11(1):100-3. PubMed ID: 19050693
[TBL] [Abstract][Full Text] [Related]
20. Incidental carcinoma of the prostate.
van Andel G; Vleeming R; Kurth K; de Reijke TM
Semin Surg Oncol; 1995; 11(1):36-45. PubMed ID: 7538693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
